Iwona Mitrus

514 total citations
26 papers, 354 citations indexed

About

Iwona Mitrus is a scholar working on Hematology, Molecular Biology and Cancer Research. According to data from OpenAlex, Iwona Mitrus has authored 26 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 7 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Iwona Mitrus's work include Hematopoietic Stem Cell Transplantation (13 papers), Mesenchymal stem cell research (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Iwona Mitrus is often cited by papers focused on Hematopoietic Stem Cell Transplantation (13 papers), Mesenchymal stem cell research (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Iwona Mitrus collaborates with scholars based in Poland, Ukraine and Denmark. Iwona Mitrus's co-authors include Stanisław Szala, Aleksander Sochanik, Tomasz Cichoń, Sebastian Giebel, Maria Saduś‐Wojciechowska, Jerzy Hołowiecki, Magdalena Głowala‐Kosińska, Ryszard Smolarczyk, Magdalena Jarosz–Biej and Ewa Missol‐Kolka and has published in prestigious journals such as Blood, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Iwona Mitrus

25 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iwona Mitrus Poland 13 136 96 81 71 48 26 354
Eun‐Yup Lee South Korea 10 131 1.0× 61 0.6× 149 1.8× 112 1.6× 21 0.4× 29 353
Sen Zhang China 10 140 1.0× 70 0.7× 121 1.5× 62 0.9× 32 0.7× 33 364
AJ Munro United Kingdom 3 227 1.7× 101 1.1× 165 2.0× 65 0.9× 84 1.8× 4 527
Feifei Chen China 11 187 1.4× 50 0.5× 37 0.5× 67 0.9× 54 1.1× 41 401
Anna Brandt Germany 9 138 1.0× 99 1.0× 109 1.3× 243 3.4× 54 1.1× 17 470
Atsushi Matsui Japan 9 166 1.2× 57 0.6× 75 0.9× 61 0.9× 22 0.5× 25 368
Nancy Wong United States 9 174 1.3× 83 0.9× 103 1.3× 180 2.5× 24 0.5× 18 559
Tracey R. O’Donovan Ireland 12 321 2.4× 68 0.7× 73 0.9× 80 1.1× 24 0.5× 20 553
Chengxin Luo China 10 119 0.9× 61 0.6× 89 1.1× 98 1.4× 44 0.9× 23 363
Eui-Jong Kwon South Korea 3 115 0.8× 43 0.4× 112 1.4× 73 1.0× 23 0.5× 7 365

Countries citing papers authored by Iwona Mitrus

Since Specialization
Citations

This map shows the geographic impact of Iwona Mitrus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iwona Mitrus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iwona Mitrus more than expected).

Fields of papers citing papers by Iwona Mitrus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iwona Mitrus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iwona Mitrus. The network helps show where Iwona Mitrus may publish in the future.

Co-authorship network of co-authors of Iwona Mitrus

This figure shows the co-authorship network connecting the top 25 collaborators of Iwona Mitrus. A scholar is included among the top collaborators of Iwona Mitrus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iwona Mitrus. Iwona Mitrus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Głowala‐Kosińska, Magdalena, Agnieszka Gdowicz‐Kłosok, Iwona Mitrus, et al.. (2025). Gemcitabine and Flurbiprofen Enhance Cytotoxic Effects on Cancer Cell Lines Mediated by Mesenchymal Stem Cells. International Journal of Molecular Sciences. 26(13). 6212–6212.
2.
3.
Czerw, Tomasz, Maria Saduś‐Wojciechowska, Magdalena Głowala‐Kosińska, et al.. (2018). Increased Efficacy of Stem Cell Chemomobilization with Intermediate-Dose Cytarabine Plus Granulocyte Colony-Stimulating Factor (G-CSF) Compared with G-CSF Alone in Patients with Multiple Myeloma: Results of a Randomized Trial. Biology of Blood and Marrow Transplantation. 25(2). 248–255. 13 indexed citations
4.
5.
Mitrus, Iwona, Magdalena Głowala‐Kosińska, Tomasz Czerw, et al.. (2017). Reduction of DMSO concentration in cryopreservation mixture from 10% to 7.5% and 5% has no impact on engraftment after autologous peripheral blood stem cell transplantation: results of a prospective, randomized study. Bone Marrow Transplantation. 53(3). 274–280. 30 indexed citations
6.
Głowala‐Kosińska, Magdalena, et al.. (2016). Thymic Activity and T Cell Repertoire Recovery after Autologous Hematopoietic Stem Cell Transplantation Preceded by Myeloablative Radiotherapy or Chemotherapy. Biology of Blood and Marrow Transplantation. 22(5). 834–842. 12 indexed citations
7.
Mitrus, Iwona, Magdalena Głowala‐Kosińska, Tomasz Czerw, et al.. (2016). Immunological properties of bone marrow microenvironment 1 year after allogeneic hematopoietic stem cell transplantation. Experimental Hematology. 44(12). 1172–1180.e1. 3 indexed citations
8.
9.
Mitrus, Iwona, Sebastian Giebel, Magdalena Głowala‐Kosińska, et al.. (2013). A faster reconstitution of hematopoiesis after autologous transplantation of hematopoietic cells cryopreserved in 7.5% dimethyl sulfoxide if compared to 10% dimethyl sulfoxide containing medium. Cryobiology. 67(3). 327–331. 28 indexed citations
10.
Mitrus, Iwona, Tomasz Cichoń, Ryszard Smolarczyk, et al.. (2013). Antitumor Effects of Recombinant Antivascular Protein ABRaA-VEGF121 Combined with IL-12 Gene Therapy. Archivum Immunologiae et Therapiae Experimentalis. 62(2). 161–168. 8 indexed citations
11.
Giebel, Sebastian, Tomasz Czerw, Maria Saduś‐Wojciechowska, et al.. (2013). Intermediate-dose Ara-C plus G-CSF for stem cell mobilization in patients with lymphoid malignancies, including predicted poor mobilizers. Bone Marrow Transplantation. 48(7). 915–921. 17 indexed citations
12.
Mitrus, Iwona, et al.. (2012). Evolving models of tumor origin and progression. Tumor Biology. 33(4). 911–917. 17 indexed citations
13.
Smolarczyk, Ryszard, Tomasz Cichoń, Sybilla Matuszczak, et al.. (2012). The Role of Glycyrrhizin, an Inhibitor of HMGB1 Protein, in Anticancer Therapy. Archivum Immunologiae et Therapiae Experimentalis. 60(5). 391–399. 64 indexed citations
14.
Mitrus, Iwona, Sebastian Giebel, Maria Saduś‐Wojciechowska, et al.. (2012). Impact of different dimethyl sulphoxide concentrations on cell recovery, viability and clonogenic potential of cryopreserved peripheral blood hematopoietic stem and progenitor cells. Vox Sanguinis. 104(3). 240–247. 20 indexed citations
15.
Mitrus, Iwona, et al.. (2012). Properties of B16-F10 murine melanoma cells subjected to metabolic stress conditions.. Acta Biochimica Polonica. 59(3). 363–6. 5 indexed citations
16.
Szala, Stanisław, Iwona Mitrus, & Aleksander Sochanik. (2010). Can inhibition of angiogenesis and stimulation of immune response be combined into a more effective antitumor therapy?. Cancer Immunology Immunotherapy. 59(10). 1449–1455. 13 indexed citations
17.
Sochanik, Aleksander, Iwona Mitrus, Ryszard Smolarczyk, et al.. (2010). Experimental Anticancer Therapy with Vascular-disruptive Peptide and Liposome-entrapped Chemotherapeutic Agent. Archivum Immunologiae et Therapiae Experimentalis. 58(3). 235–245. 5 indexed citations
18.
Mitrus, Iwona, et al.. (2006). Combination of IL-12 gene therapy and CTX chemotherapy inhibits growth of primary B16(F10) melanoma tumors in mice.. Acta Biochimica Polonica. 53(2). 357–360. 11 indexed citations
19.
Mitrus, Iwona, Ewa Missol‐Kolka, Andrzej Płucienniczak, & Stanisław Szala. (2005). Tumour therapy with genes encoding apoptin and E4orf4.. PubMed. 25(2A). 1087–90. 24 indexed citations
20.
Sochanik, Aleksander, et al.. (2000). A new cholesterol derivative suitable for transfecting certain type of cells in the presence of 10% serum. Cancer Gene Therapy. 7(4). 513–520. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eun‐Yup Lee Breakdown of academic impact, for papers by Sen Zhang Breakdown of academic impact, for papers by AJ Munro Breakdown of academic impact, for papers by Feifei Chen Breakdown of academic impact, for papers by Anna Brandt Breakdown of academic impact, for papers by Atsushi Matsui Breakdown of academic impact, for papers by Nancy Wong Breakdown of academic impact, for papers by Tracey R. O’Donovan Breakdown of academic impact, for papers by Chengxin Luo Breakdown of academic impact, for papers by Eui-Jong Kwon
Rankless by CCL
2026